Search found 1 match
- Fri Aug 12, 2011 5:34 am
- Forum: Aimspro
- Topic: Aimspro in Multiple Sclerosis study recruiting
- Replies: 5
- Views: 11428
Daval International announced the completion of the treatment period of its randomised, placebo-controlled, double blind Phase II Study, Treating Patients with Bladder Dysfunction with Aimspro in Secondary Progressive Multiple Sclerosis (SPMS). Standard clinical measures and assessment scores record...